Patent details

Basic Information

Publication number:

EP1799685

PCT Application Number:

PCT/IB/2005/002941

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP057999914

PCT Publication Number:

WO/2006/033007

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

POLYMORPHIC FORMS OF THE PHOSPHATE SALT OF 8-FLUORO-2-{4-Ö(METHYLAMINO)METHYLÜPHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINOÖ5,4,3-CDÜINDOL-6-ONE

French Title of Invention:

FORMULES POLYMORPHES DE SEL DE PHOSPHATE DE 8-FLUORO-2-{4-Ö(METHYLAMINO)METHYLÜPHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINOÖ5,4,3-CDÜINDOL-6-ONE

German Title of Invention:

POLYMORPHE FORMEN DES PHOSPHATSALZES VON 8-FLUOR-2-{4-Ö(METHYLAMINO)METHYLÜPHENYL}-1,3,4,5-TETRAHYDRO-6H-AZEPINOÖ5,4,3-CDÜINDOL-6-ON

SPC Number:

Dates

Filing date:

12/09/2005

Grant date:

28/03/2012

EP Publication Date:

28/03/2012

PCT Publication Date:

30/03/2006

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/06/2007

EP B1 Publication Date:

28/03/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

12/09/2012

Expiration date:

12/09/2025

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/09/2005

 

 

Name:

Cancer Research Technology Limited

Address:

Sardinia House, Sardinia Street, London WC2A 3NL, United Kingdom (GB)

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

1

Name:

MITCHELL Mark B., Agouron Pharmaceuticals, Inc.

Address:

United States (US)

2

Name:

CHU Jan-Jon, Agouron Pharmaceuticals, Inc.

Address:

United States (US)

3

Name:

BORER Bennett C. Agouron Pharmaceuticals, Inc.

Address:

United States (US)

4

Name:

WU Zhen-Ping, Agouron Pharmaceuticals, Inc.

Address:

United States (US)

5

Name:

SRIRANGAM A.N., Agouron Pharmaceuticals, Inc.

Address:

United States (US)

6

Name:

GUO Ming Agouron Pharmaceuticals, Inc. A Pfizer Compan

Address:

United States (US)

7

Name:

LI Yi, Agouron Pharmaceuticals, Inc.

Address:

United States (US)

8

Name:

NAYYAR Naresh, Agouron Pharmaceuticals, Inc.

Address:

United States (US)

9

Name:

LIU Jia, Agouron Pharmaceuticals, Inc.

Address:

United States (US)

Priority

1

Priority Number:

612459 P

Priority Date:

22/09/2004

Priority Country:

United States (US)

2

Priority Number:

679296 P

Priority Date:

09/05/2005

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 487/06;

Filing date	Document type	Number of pages